Mineralys Therapeutics to Participate in the Bank of America Securities Health Care Conference

Rhea-AI Summary

Mineralys Therapeutics, a clinical-stage biopharmaceutical company, will participate in a fireside chat at the Bank of America Securities Health Care Conference. The company focuses on developing medicines for hypertension, chronic kidney disease, and diseases driven by dysregulated aldosterone. The event will take place in Las Vegas on May 14-16, 2024. Investors can access a live webcast and replay of the chat on the company's website.

RADNOR, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by dysregulated aldosterone, today announced that management will be participating in a fireside chat at the Bank of America Securities Health Care Conference, being held in Las Vegas on May 14-16, 2024.

Bank of America Securities Health Care Conference:
Date:	Wednesday, May 15, 2024
Time:	5:00pm PDT
Format:	Fireside Chat

A live webcast of the fireside chat can be accessed by clicking here or under “News and Events” on the Investor Relations section of the Mineralys website at www.mineralystx.com. A replay of the fireside chat will be available on the Company’s website for approximately 90 days.

About Mineralys Therapeutics
Mineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, CKD and other diseases driven by dysregulated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that Mineralys Therapeutics is developing for cardiorenal conditions affected by dysregulated aldosterone, including hypertension and CKD. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Follow Mineralys on LinkedIn and Twitter.

Contact:
Investor Relations
investorrelations@mineralystx.com

Media Relations
Tom Weible
Elixir Health Public Relations
Phone: (1) 515-707-9678
Email: tweible@elixirhealthpr.com

FAQ

What is the focus of Mineralys Therapeutics?

Mineralys Therapeutics focuses on developing medicines for hypertension, chronic kidney disease, and diseases driven by dysregulated aldosterone.

When will Mineralys Therapeutics participate in the Bank of America Securities Health Care Conference?

Mineralys Therapeutics will participate in the Bank of America Securities Health Care Conference on May 14-16, 2024.

Where will the Bank of America Securities Health Care Conference take place?

The Bank of America Securities Health Care Conference will be held in Las Vegas.

How can investors access the live webcast of the fireside chat?

Investors can access the live webcast of the fireside chat by clicking on the link provided on the company's website.

How long will the replay of the fireside chat be available on the company's website?

The replay of the fireside chat will be available on the company's website for approximately 90 days.